Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 345 institutions that hold shares in the stock, with a total of 98.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.17 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
Feb 10, 2025 Q4 2024 |
731,900
shares
|
$15.8 Million
0.07% of portfolio
|
Q4 2024
Added 74.3%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
722,858
shares
|
$15.6 Million
0.0% of portfolio
|
Q4 2024
Added 239.62%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Feb 12, 2025 Q4 2024 |
698,152
shares
|
$15.1 Million
0.01% of portfolio
|
Q4 2024
Added 131.45%
|
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
682,652
shares
|
$14.8 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
659,252
shares
|
$14.3 Million
0.02% of portfolio
|
Q4 2024
Reduced 1.2%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
600,488
shares
|
$13 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
553,424
shares
|
$12 Million
0.02% of portfolio
|
Q4 2024
Added 30.25%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Feb 14, 2025 Q4 2024 |
531,836
shares
|
$11.5 Million
0.04% of portfolio
|
Q4 2024
Reduced 30.68%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
520,778
shares
|
$11.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 6.97%
|
|
|
Abrdn PLC
|
Jan 24, 2025 Q4 2024 |
484,666
shares
|
$10.5 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Jupiter Asset Management LTD
|
Feb 10, 2025 Q4 2024 |
481,987
shares
|
$10.4 Million
0.1% of portfolio
|
Q4 2024
Reduced 31.14%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
477,011
shares
|
$10.3 Million
0.01% of portfolio
|
Q4 2024
Added 3.84%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
476,023
shares
|
$10.3 Million
0.01% of portfolio
|
Q4 2024
Added 32.16%
|
|
|
Oberweis Asset Management Inc
Lisle, IL |
Feb 14, 2025 Q4 2024 |
467,100
shares
|
$10.1 Million
0.48% of portfolio
|
Q4 2024
Added 1.9%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
436,467
shares
|
$9.44 Million
0.0% of portfolio
|
Q4 2024
Added 1629.4%
|
|
|
Gables Capital Management Inc.
|
Feb 07, 2025 Q4 2024 |
417,551
shares
|
$9.03 Million
4.28% of portfolio
|
Q4 2024
Reduced 2.27%
|
|
|
Allspring Global Investments Holdings, LLC
|
Jan 29, 2025 Q4 2024 |
417,332
shares
|
$9.02 Million
0.01% of portfolio
|
Q4 2024
Added 13.89%
|
|
|
Jw Asset Management, LLC
Armonk, NY |
Feb 07, 2025 Q4 2024 |
413,392
shares
|
$8.94 Million
4.2% of portfolio
|
Q4 2023
Reduced 26.62%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
349,649
shares
|
$7.56 Million
1.2% of portfolio
|
Q4 2024
Reduced 16.32%
|
|
|
Legal & General Group PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
344,623
shares
|
$7.45 Million
0.0% of portfolio
|
Q4 2024
Added 2.91%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Feb 06, 2025 Q4 2024 |
329,980
shares
|
$7.13 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
315,817
shares
|
$6.83 Million
0.02% of portfolio
|
Q4 2024
Added 24.0%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
312,320
shares
|
$6.75 Million
0.01% of portfolio
|
Q4 2024
Added 0.31%
|
|
|
Friess Associates LLC
Greenville, DE |
Aug 15, 2022 Q2 2022 |
305,148
shares
|
$6.6 Million
3.57% of portfolio
|
Q2 2022
Reduced 46.65%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
300,000
shares
|
$6.49 Million
0.56% of portfolio
|
Q4 2024
Reduced 25.0%
|